Cargando…

ADAMTS13, TTP and Beyond

Detalles Bibliográficos
Autor principal:	Zheng, X Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001087/ https://www.ncbi.nlm.nih.gov/pubmed/24790789 http://dx.doi.org/10.4172/2161-1041.1000e104

Ejemplares similares

P1612: CALPROTECTIN LEVELS ARE ELEVATED IN CONGENITAL TTP AND IMMUNE TTP AT ADAMTS13 RELAPSE
por: Subhan, Maryam, et al.
Publicado: (2023)

An Imperfect Marker: SLE and TTP-Like MAHA Without Low ADAMTS13
por: Chiruvolu, Neha V., et al.
Publicado: (2021)

P1598: UTILITY OF ‘OPEN/CLOSED’ ADAMTS13 IN MONITORING IMMUNE TTP
por: Prasannan, Nithya, et al.
Publicado: (2023)

Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
por: De Waele, Laure, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura (TTP) response following COVID‐19 infection: Implications for the ADAMTS‐13–von Willebrand factor axis
por: Maharaj, Satish, et al.
Publicado: (2021)

Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker
por: Wendt, Ralph, et al.
Publicado: (2021)

Low ADAMTS‐13 predicts adverse outcomes in hospitalized patients with suspected heparin‐induced thrombocytopenia
por: Chan, Meng, et al.
Publicado: (2021)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Mechanisms of ADAMTS13 regulation
por: DeYoung, Veronica, et al.
Publicado: (2022)

Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase
por: Westwood, John Paul, et al.
Publicado: (2022)

Disappearing acts of ADAMTS13
por: Voorberg, Jan, et al.
Publicado: (2015)

Histone-induced thrombotic thrombocytopenic purpura in adamts13(−/−) zebrafish depends on von Willebrand factor
por: Zheng, Liang, et al.
Publicado: (2020)

Systemic antithrombotic effects of ADAMTS13
por: Chauhan, Anil K., et al.
Publicado: (2006)

ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice
por: Zitomersky, Naamah L., et al.
Publicado: (2017)

A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen−deuterium exchange plus mass spectrometry
por: Pillai, Vikram G., et al.
Publicado: (2022)

Reduced ADAMTS13 activity is associated with an ADAMTS13 SNP, fever and microparticles in a malaria-like model
por: Kraisin, Sirima, et al.
Publicado: (2014)

Frequency of Pro475Ser Polymorphism of ADAMTS13 Gene and Its Association with ADAMTS-13 Activity in the Korean Population
por: Jang, Mun Ju, et al.
Publicado: (2008)

Further characterization of ADAMTS-13 inactivation by thrombin
por: LAM, J K, et al.
Publicado: (2007)

Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis
por: Uemura, Masahito, et al.
Publicado: (2011)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Association of ADAMTS13 polymorphism with cerebral malaria
por: Kraisin, Sirima, et al.
Publicado: (2011)

ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
por: Sarig, Galit
Publicado: (2014)

Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)

ADAMTS13: An Emerging Target in Stroke Therapy
por: Chen, Xin, et al.
Publicado: (2019)

Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity
por: Ercig, Bogac, et al.
Publicado: (2021)

Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty
por: He, Jun Kit, et al.
Publicado: (2022)

Novel mutations in ADAMTS13 CUB domains cause abnormal pre‐mRNA splicing and defective secretion of ADAMTS13
por: Jiang, Yizhi, et al.
Publicado: (2020)

Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device support
por: Ito, Toshihiro, et al.
Publicado: (2021)

Cerebral Infarction in Immune Thrombotic Thrombocytopenic Purpura Is Associated with Old Age, Hypertension, Smoking, and Anti-ADAMTS13 Ig, But Not with Mortality
por: Memon, Raima, et al.
Publicado: (2021)

Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
por: Kangro, Kadri, et al.
Publicado: (2020)

Multilevel regulation of HIF-1 signaling by TTP
por: Fähling, Michael, et al.
Publicado: (2012)

Analysis of ROQUIN, Tristetraprolin (TTP), and BDNF/miR-16/TTP regulatory axis in late onset Alzheimer’s disease
por: Asadi, Mohammad Reza, et al.
Publicado: (2022)

Crystal structure and substrate-induced activation of ADAMTS13
por: Petri, Anastasis, et al.
Publicado: (2019)

Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells
por: Tati, Ramesh, et al.
Publicado: (2011)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)
por: King, Jeanelle, et al.
Publicado: (2017)

From TTP to Glomerulonephritis: A Lifetime of Lupus
por: Kharouf, Fadi, et al.
Publicado: (2021)

PB2322: TTP AFTER COVID 19
por: Gagloeva, D., et al.
Publicado: (2022)

Successful Use of Bortezomib in an Adolescent with Refractory TTP
por: Wali, Junaid Ahmad, et al.
Publicado: (2023)

ADAMTS and ADAM metalloproteinases in osteoarthritis – looking beyond the ‘usual suspects’
por: Yang, C.-Y., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vnpt6343l4g02c7fbqoj8a0k2o